The phrase "architecture of samples" is correct and usable in written English.
It can be used in contexts related to design, structure, or organization of samples, particularly in fields like data analysis, research, or software development.
Example: "The architecture of samples in this study allows for a comprehensive analysis of the data collected."
Alternatives: "structure of samples" or "design of samples".
The pore architecture of adsorbent samples was analysed through corresponding surface chemistry, N2 sorption isotherm, pore size distribution (PSD) plot, Brunauer Emmett Teller (BET), Barett Joyner–Halenda (BJH) model and scanning electron microscopy (SEM).
Both schematic presentation of deposition process and the architecture of the samples are shown in Fig. 1.
Taking into account the architecture of the samples (Fig. 1), the presence of Zr ions inside SiO2 interfacial and capping layers as well as the presence of contaminated Si ions in ZrO2 core (Fig. 4), we can attribute the band peaked at 960 980 cm−1 to Si-O-Zr vibrations.
X-ray tomography was used to characterize the architecture of the sample.
A 6-bit high-speed analog-to-digital converter was implemented utilizing a novel distributed sample-and-hold architecture capable of sampling and subtracting the input preamplifier's offset.
Traditional Iranian architecture is full of samples evolved during the course of Iranian history that can serve as architectural paragons of the city.
Pyclone was employed to infer the subclonal architecture of all DNA samples from plasma and available SCLC tumors20.
Changes in the architecture of the model samples were readily detected as systematic variations in shape and displacements on Cole-Cole plot.
As shown in Figure 6B (panel a), the mucosa architecture of the uninfected samples remained unaltered and only scattered inflammatory cells were interspersed throughout the chorion.
It is well known that four capital factors of genome-wide association studies (GWAS) consisting of models of the allelic architecture of common diseases, sample size, map density and sample-collection biases need to be taken into account in order to optimize the cost efficiency of identifying precise disease-susceptibility loci [ 39].
